CTNI-48. NOVEL TREATMENT OF END STAGE RECURRENT GLIOBLASTOMA TREATED WITH A NONINVASIVE ONCOMAGNETIC DEVICE USING OSCILLATING MAGNETIC FIELDS – A NEW AND POWERFUL NONINVASIVE THERAPY

Noninvasive treatment with alternating electric fields at 200 kHz (Optune therapy) has been approved for recurrent and newly diagnosed glioblastoma (GBM). We have recently tested and confirmed in vitro, and in patient derived xenografted mouse models, the oncolytic potential of powerful newly develo...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Helekar, Santosh, Sharpe, Martyn, Pichumani, Kumar, Ijare, Omkar, Nguyen, Lisa, Baskin, David
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Clinical Trials: Non-Immunologic
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650985/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.214
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы